However, randomised control trial data is lacking and the reported cases of incomplete clinical response suggest that IL-1 signalling may not play a dominant pathogenic role in all patients with pustular psoriasis [151, 169–171]. This evidence concerns the gene IL1B and pustular psoriasis.